atHeart Medical

atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects. We have initiated the U.S. FDA approved ASCENT-ASD pivotal trial in the United States and internationally to demonstrate the safety and efficacy of our reSept ASD Occluder for treating patients with clinically significant, isolated ASD. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart

Atheart medical operates in the Medical equipment manufacturing industry.

Atheart medical's revenue is 11m - 100m

Atheart medical has 11 - 50 employees.